The highest estimate is 85.00. From 4 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow MANE. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Veradermics, Incorporated operates as a biopharmaceutical company focused on developing novel therapeutics for dermatologic and aesthetic conditions. The company develops treatments for Pattern Hair Loss affecting adults and children. The company's products include VDPHL01, an oral, non-hormonal treatment for men and women with PHL for chronic hair loss therapy. Additionally, it engages in the development of VDMN, a dissolvable microarray patch technology for immunotherapy of common warts; VDAA for the treatment of alopecia areata; and VDMC for the treatment of molluscum contagiosum. Its products are used for the treatment of androgenetic alopecia, common warts, molluscum contagiosum, alopecia areata, and atopic dermatitis. The company serves healthcare providers and clinicians treating dermatologic and aesthetic conditions in both adult and pediatric populations, as well as the broader medical and clinical research community involved in dermatology. Veradermics, Incorporated was founded in 2019 and is based in New Haven, Connecticut.
The current price of MANE is $63.82 USD — it has decreased by -0.58% in the past 24 hours. Watch Veradermics stock price performance more closely on the chart.
What is Veradermics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Veradermics stocks are traded under the ticker MANE.
When is the next Veradermics earnings date?▼
Veradermics is going to release the next earnings report on June 03, 2026.
What were Veradermics earnings last quarter?▼
MANE earnings for the last quarter are -1.06 USD per share, whereas the estimation was -1.81 USD resulting in a +41.47% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Veradermics revenue for the last year?▼
Veradermics revenue for the last year amounts to 0 USD.
What is Veradermics net income for the last year?▼